Editorial
Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science
Drug Safety · 18.08.2026
DOI: 10.1007/s40264-026-01713-2 ↗Kurz gefasst
Editorial in der Zeitschrift Drug Safety, online erschienen am 18.08.2026. Verfasst von Deborah Layton und 1 weiteren Autor:innen. Beteiligte Einrichtung: PEPI Consultancy Limited, 3 Neilson Close, Eastleigh, Hampshire, UK. drdeborahlayton@outlook.com. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- PEPI Consultancy Limited, 3 Neilson Close, Eastleigh, Hampshire, UK. drdeborahlayton@outlook.com.
- PHARMO, part of Lumanity, Utrecht, The Netherlands. drdeborahlayton@outlook.com.
- School of Life Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK. drdeborahlayton@outlook.com.
- Celltrion Healthcare, Uxbridge, Middlesex, UK.
Zitieren
APA
Layton, D., & Rishiraj, P. (2026). Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science. Drug Safety. https://doi.org/10.1007/s40264-026-01713-2
Vancouver
Layton D, Rishiraj P. Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science. Drug Safety. 2026. doi:10.1007/s40264-026-01713-2
BibTeX
@article{Layton2026,
author = {Layton, Deborah and Rishiraj, Pav},
title = {Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science},
journal = {Drug Safety},
year = {2026},
doi = {10.1007/s40264-026-01713-2}
}
EUVIMED